NASDAQ NMS - GLOBAL MARKET · DARE
+0.00% · +$0.0000 · Vol 56.3K
After hours · updated 16:00:00 ET
Dare Bioscience Inc

Dare Bioscience Inc

Pharmaceuticals
$1.34
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
DARE
Dare Bioscience Inc
Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

52/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is DARE moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading DARE catalysts
About Dare Bioscience Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2014
Employees
24
Country
US

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.32
Day high
$1.38
Day low
$1.30
Previous close
$1.34
52W high
$3.27
-59.02% from high
52W low
$1.16
9% of range
Market cap
$20.1M
EPS
$-1.4400
Beta
1.80
Shares out
15M
Volume
56.3K
0.32× rel vol
Avg volume
175K
VWAP
$1.33
Price history computed in-house
1W
+15.52%
1M
-35.58%
3M
-53.95%
1Y
-44.17%
YTD
-30.57%
SMA 50 $1.87 · below
SMA 200 $1.93 · below
52W position 9%

DARE overview

Veridion Score
52
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around DARE.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading DARE Form 4 filings
Public disclosures

Congress activity in DARE

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for DARE in the cached public ledger.

Federal contracts

DARE contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DARE in this window.
Lobbying spend

DARE lobbying filings, year to date.

Registered lobbying filings matched to Dare Bioscience Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for DARE in this window.
Loading news for DARE
Analyst ratings
Sovereign unlock shows live analyst consensus for DARE.
Options
Sovereign unlock shows live options positioning for DARE.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.